November 2026
1. JIMENEZ-CAMACHO KE, Vargas-Robles H, Adomako J, Sanchez-Argaez AB, et al
   HDAC6 is a biomarker of leukaemic dissemination and relapse in B-ALL.
   Br J Cancer. 2026;135:1470-1482.
   

   >> Share

   
   
2. BANSAL S, Gupta AK, Meena JP, Sehgal T, et al
   Romiplostim for chemotherapy induced thrombocytopenia in pediatric cancers.
   Br J Cancer. 2026;135:1417-1423.
   

   >> Share

   
   October 2026
3. KARAKULAK T, Moch H, von Mering C, Kahraman A, et al
   Switches in alternatively spliced isoforms impact protein and drug interactions in melanoma, ovarian cancer, and acute myeloid leukemia.
   Br J Cancer. 2026 Oct 3. doi: 10.1038/s41416-026-03638.
   

   >> Share

   
   
4. OZCAN SG, Stanko C, Szymanski L, Fischer M, et al
   Revisiting retinoic acid in AML therapy: mechanisms of action and rational combination strategies.
   Br J Cancer. 2026;135:1196-1206.
   

   >> Share

   
   August 2026
5. HOUMERA N, Genestier L, Huet S
   Next-generation models for lymphoid malignancies: the rise of 3D culture systems in translational hematology.
   Br J Cancer. 2026;135:336-348.
   

   >> Share

   
   July 2026
6. ASKAR B, Heaton S, Barr T, Baugh R, et al
   Apoptotic modulators enhance oncolytic virus-induced cytokine killing in acute myeloid leukaemia (AML).
   Br J Cancer. 2026;135:152-162.
   

   >> Share

   
   June 2026
7. CHEN X, Ma X, Yuan L, Wang F, et al
   TCF3::HLF-positive B-ALL: integrated clinical and molecular characterization of 34 cases from a single-center cohort.
   Br J Cancer. 2026;134:1646-1657.
   

   >> Share

   
   December 2025
8. WACHTMEISTER A, Bang B, Nordgren I, Martling A, et al
   Lifetime risk of solid tumors and leukemia in Down Syndrome: a population-based Swedish matched cohort study.
   Br J Cancer. 2025 Dec 26. doi: 10.1038/s41416-025-03318.
   

   >> Share

   
   September 2025
9. GIL JV, Avetisyan G, Miralles A, de Las Heras S, et al
   Benchmarking standard-of-care and emerging genomic approaches to enhance diagnosis in pediatric acute lymphoblastic leukemia.
   Br J Cancer. 2025 Sep 30. doi: 10.1038/s41416-025-03204.
   

   >> Share

   
   
10. LAN Y, Deng J, He P, Huang W, et al
    Innovative rapid screening for complex BCR-ABL1 kinase domain mutations in TKI-treated leukaemia patients.
    Br J Cancer. 2025;133:674-684.
    

    >> Share

    
    April 2025
11. TRINQUAND A, Leveson J, Barbosa AL, Gameiro P, et al
    ALLTogether recommendations for biobanking samples from patients with acute lymphoblastic leukaemia: a modified Delphi study.
    Br J Cancer. 2025;132:493-501.
    

    >> Share

    
    August 2024
12. PACKNESS E, Davidsson OB, Rostgaard K, Andersen MA, et al
    Infections and their prognostic significance before diagnosis of chronic lymphocytic leukemia, non-Hodgkin lymphoma, or multiple myeloma.
    Br J Cancer. 2024 Aug 22. doi: 10.1038/s41416-024-02816.
    

    >> Share

    
    
13. SINHA S, Guo R, Del Busso MD, Han W, et al
    Aberrant activation of AXL may drive progression of squamous cell carcinoma in CLL patients: a mechanistic study with clinical implications.
    Br J Cancer. 2024;131:589-600.
    

    >> Share

    
    May 2024
14. MEDRANO M, Contreras M, Caballero-Velazquez T, Martinez L, et al
    Cannabinoids induce cell death in leukaemic cells through Parthanatos and PARP-related metabolic disruptions.
    Br J Cancer. 2024;130:1529-1541.
    

    >> Share

    
    March 2024
15. LITTLE MP, Eidemuller M, Kaiser JC, Apostoaei AI, et al
    Minimum latency effects for cancer associated with exposures to radiation or other carcinogens.
    Br J Cancer. 2024;130:819-829.
    

    >> Share

    
    February 2024
16. LITTLE MP, Mai JZ, Fang M, Chernyavskiy P, et al
    Solar ultraviolet radiation exposure, and incidence of childhood acute lymphocytic leukaemia and non-Hodgkin lymphoma in a US population-based dataset.
    Br J Cancer. 2024 Feb 29. doi: 10.1038/s41416-024-02629.
    

    >> Share

    
    
17. ZAKKAK N, Barclay ME, Swann R, McPhail S, et al
    The presenting symptom signatures of incident cancer: evidence from the English 2018 National Cancer Diagnosis Audit.
    Br J Cancer. 2024;130:297-307.
    

    >> Share

    
    
18. GUTIERREZ-CAMINO A, Richer C, Ouimet M, Fuchs C, et al
    Characterisation of FLT3 alterations in childhood acute lymphoblastic leukaemia.
    Br J Cancer. 2024;130:317-326.
    

    >> Share

    
    January 2024
19. HEYMER EJ, Hawkins MM, Winter DL, Teepen JC, et al
    Risk of subsequent gliomas and meningiomas among 69,460 5-year survivors of childhood and adolescent cancer in Europe: the PanCareSurFup study.
    Br J Cancer. 2024 Jan 19. doi: 10.1038/s41416-024-02577.
    

    >> Share

    
    October 2023
20. LITTLE MP, Wakeford R, Zablotska LB, Borrego D, et al
    Radiation exposure and leukaemia risk among cohorts of persons exposed to low and moderate doses of external ionising radiation in childhood.
    Br J Cancer. 2023;129:1152-1165.
    

    >> Share

    
    
21. ENSSLE JC, Wolf S, Scheich S, Weber S, et al
    Impact of BMI on patient outcome in acute myeloid leukaemia patients receiving intensive induction therapy: a real-world registry experience.
    Br J Cancer. 2023;129:1126-1133.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share